Literature DB >> 27761601

KV7 channels in the human detrusor: channel modulator effects and gene and protein expression.

Riccardo Bientinesi1, Cesare Mancuso2, Maria Martire2, Pier Francesco Bassi1, Emilio Sacco1, Diego Currò3.   

Abstract

Voltage-gated type 7 K+ (KV7 or KCNQ) channels regulate the contractility of various smooth muscles. With this study, we aimed to assess the role of KV7 channels in the regulation of human detrusor contractility, as well as the gene and protein expression of KV7 channels in this tissue. For these purposes, the isolated organ technique, RT-qPCR, and Western blot were used, respectively. XE-991, a selective KV7 channel blocker, concentration-dependently contracted the human detrusor; mean EC50 and Emax of XE-991-induced concentration-response curve were 14.1 μM and 28.8 % of the maximal bethanechol-induced contraction, respectively. Flupirtine and retigabine, selective KV7.2-7.5 channel activators, induced concentration-dependent relaxations of bethanechol-precontracted strips, with maximal relaxations of 51.6 and 51.8 % of the precontraction, respectively. XE-991 blocked the relaxations induced by flupirtine and retigabine. All five KCNQ genes were found to be expressed in the detrusor with KCNQ4 being the most expressed among them. Different bands, having sizes similar to some of reported KV7.1, 7.4, and 7.5 channel subunit isoforms, were detected in the detrusor by Western blot with the KV7.4 band being the most intense among them. In conclusion, KV7 channels contribute to set the basal tone of the human detrusor. In addition, KV7 channel activators significantly relax the detrusor. The KV7.4 channels are probably the most important KV7 channels expressed in the human detrusor. These data suggest that selective KV7.4 channel activators might represent new pharmacological tools for inducing therapeutic relaxation of the detrusor.

Entities:  

Keywords:  Flupirtine; Human detrusor; KCNQ channels; KV7 channels; Retigabine; XE-991

Mesh:

Substances:

Year:  2016        PMID: 27761601     DOI: 10.1007/s00210-016-1312-9

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  34 in total

1.  KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.

Authors:  H S Wang; Z Pan; W Shi; B S Brown; R S Wymore; I S Cohen; J E Dixon; D McKinnon
Journal:  Science       Date:  1998-12-04       Impact factor: 47.728

2.  Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder.

Authors:  Frederik Rode; Julie Svalø; Majid Sheykhzade; Lars Christian B Rønn
Journal:  Eur J Pharmacol       Date:  2010-04-10       Impact factor: 4.432

3.  Investigations into the mechanism of action of the new anticonvulsant retigabine. Interaction with GABAergic and glutamatergic neurotransmission and with voltage gated ion channels.

Authors:  C Rundfeldt; R Netzer
Journal:  Arzneimittelforschung       Date:  2000-12

4.  Electrophysiological and functional effects of the KCNQ channel blocker XE991 on murine portal vein smooth muscle cells.

Authors:  Shuk Yin M Yeung; Iain A Greenwood
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

5.  Is the bladder a reliable witness for predicting detrusor overactivity?

Authors:  H Hashim; P Abrams
Journal:  J Urol       Date:  2006-01       Impact factor: 7.450

6.  Kv 7 positive modulators reduce detrusor overactivity and increase bladder capacity in rats.

Authors:  Julie Svalø; Henrik H Hansen; Lars Christian B Rønn; Majid Sheykhzade; Gordon Munro; Frederik Rode
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-09-06       Impact factor: 4.080

7.  Electrical properties of detrusor smooth muscles from the pig and human urinary bladder.

Authors:  Hikaru Hashitani; Alison F Brading
Journal:  Br J Pharmacol       Date:  2003-06-09       Impact factor: 8.739

8.  K+ channels as potential targets for the treatment of gastrointestinal motor disorders.

Authors:  Diego Currò
Journal:  Eur J Pharmacol       Date:  2014-04-13       Impact factor: 4.432

Review 9.  Driving with no brakes: molecular pathophysiology of Kv7 potassium channels.

Authors:  Maria Virginia Soldovieri; Francesco Miceli; Maurizio Taglialatela
Journal:  Physiology (Bethesda)       Date:  2011-10

10.  Functional expression of KCNQ (Kv7) channels in guinea pig bladder smooth muscle and their contribution to spontaneous activity.

Authors:  U A Anderson; C Carson; L Johnston; S Joshi; A M Gurney; K D McCloskey
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

View more
  5 in total

1.  KV7 Channel Pharmacological Activation by the Novel Activator ML213: Role for Heteromeric KV7.4/KV7.5 Channels in Guinea Pig Detrusor Smooth Muscle Function.

Authors:  Aaron Provence; Damiano Angoli; Georgi V Petkov
Journal:  J Pharmacol Exp Ther       Date:  2017-10-30       Impact factor: 4.030

Review 2.  Urinary bladder smooth muscle ion channels: expression, function, and regulation in health and disease.

Authors:  John Malysz; Georgi V Petkov
Journal:  Am J Physiol Renal Physiol       Date:  2020-07-06

3.  The Effectiveness in Activating M-Type K+ Current Produced by Solifenacin ([(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate): Independent of Its Antimuscarinic Action.

Authors:  Hsin-Yen Cho; Tzu-Hsien Chuang; Sheng-Nan Wu
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

4.  KCNQ3 is the principal target of retigabine in CA1 and subicular excitatory neurons.

Authors:  Nissi Varghese; Anna Lauritano; Maurizio Taglialatela; Anastasios V Tzingounis
Journal:  J Neurophysiol       Date:  2021-03-17       Impact factor: 2.714

5.  Inhibition of Spontaneous Contractility of Isolated Caprine Ureter by Flupirtine.

Authors:  Girish S Naik; Rohit Kodagali; Manoj G Tyagi; Kalpana Ernest; Margaret Shanthi; Sumith K Mathew; Jacob Peedicayil
Journal:  Int J Appl Basic Med Res       Date:  2018 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.